Cargando…
Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
OBJECTIVES: This study aimed to characterize corrected QT (QTc) prolongation in a cohort of hospitalized patients with coronavirus disease-2019 (COVID-19) who were treated with hydroxychloroquine and azithromycin (HCQ/AZM). BACKGROUND: HCQ/AZM is being widely used to treat COVID-19 despite the known...
Autores principales: | O’Connell, Thomas F., Bradley, Christopher J., Abbas, Amr E., Williamson, Brian D., Rusia, Akash, Tawney, Adam M., Gaines, Rick, Schott, Jason, Dmitrienko, Alex, Haines, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406234/ https://www.ncbi.nlm.nih.gov/pubmed/33478708 http://dx.doi.org/10.1016/j.jacep.2020.07.016 |
Ejemplares similares
-
QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020) -
Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020) -
Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022) -
Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)